EMMAC Life Sciences Group Secures GDP licence for Swiss pharmaceutical entity, EMMAC SAGL Approved to import, distribute and export medicinal products for domestic, EU and international markets LONDON, Aug. 18, 2020 (GLOBE NEWSWIRE) -- EMMAC Life Sciences Group (”EMMAC” or the “Group” or the “Company”), Europe’s largest independent cannabis company, is pleased to announce that EMMAC SAGL,...

EMMAC Life Sciences Group (”EMMAC” or the “Group” or the “Company”) Medalchemy receives licence for cultivation of medical cannabis Spanish EU GMP Facility now has licences to cultivate, extract and manufacture cannabis extract EMMAC now licensed to cultivate medical cannabis in Portugal and Spain   LONDON, July 28, 2020 (GLOBE...